A detailed history of Virtu Financial LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 29,491 shares of AVIR stock, worth $93,191. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,491
Holding current value
$93,191
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$3.17 - $4.02 $93,486 - $118,553
29,491 New
29,491 $99,000
Q3 2022

Nov 07, 2022

BUY
$5.49 - $8.79 $168,504 - $269,791
30,693 New
30,693 $175,000
Q4 2021

Feb 17, 2022

SELL
$7.67 - $44.59 $203,423 - $1.18 Million
-26,522 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$21.33 - $35.06 $565,714 - $929,861
26,522 New
26,522 $930,000
Q2 2021

Sep 17, 2021

SELL
$19.22 - $59.08 $108,131 - $332,384
-5,626 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$41.42 - $88.44 $233,028 - $497,563
5,626 New
5,626 $347,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $263M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.